Cargando…
A validation of presepsin levels in kidney dysfunction patients: four case reports
Here, we measured presepsins (PSPs) in four patients with acute kidney injury (AKI) or chronic kidney disease (CKD) and discuss the relationship between PSP and kidney dysfunction. Case 1: an 83-year-old man was admitted to the ICU to manage postoperative respiratory failure with AKI. He had undergo...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4336244/ https://www.ncbi.nlm.nih.gov/pubmed/25705419 http://dx.doi.org/10.1186/s40560-014-0063-2 |
_version_ | 1782358437706858496 |
---|---|
author | Kotera, Atsushi Sagishima, Katsuyuki Tashiro, Takahiro Niimori, Daisuke Kamohara, Hidenobu Kinoshita, Yoshihiro |
author_facet | Kotera, Atsushi Sagishima, Katsuyuki Tashiro, Takahiro Niimori, Daisuke Kamohara, Hidenobu Kinoshita, Yoshihiro |
author_sort | Kotera, Atsushi |
collection | PubMed |
description | Here, we measured presepsins (PSPs) in four patients with acute kidney injury (AKI) or chronic kidney disease (CKD) and discuss the relationship between PSP and kidney dysfunction. Case 1: an 83-year-old man was admitted to the ICU to manage postoperative respiratory failure with AKI. He had undergone resection for rectal cancer and ileal conduit replacement. On day 1 in the ICU, Escherichia coli (E. coli) was isolated by urine culture. PSP level (pg/ml) on day 2 was 2,745 without elevation of other conventional biomarkers. On day 6, the patient was diagnosed with severe sepsis, and E. coli was isolated by blood culture. By then, PSP had risen to 3,977, along with elevation of other conventional biomarkers. His kidney function recovered gradually after continuous administration of hemodiafiltration; however, PSP continued to rise up to 6,051, along with high systemic inflammatory response syndrome (SIRS) and Acute Physiology and Chronic Health Evaluation (APACHE) II values. The patient expired on day 13 due to multiple organ failure. Case 2: a 78-year-old woman with CKD on hemodialysis (HD) was admitted to the ICU after cardiovascular surgery. Continuous HD was administered postoperatively, and PSP ranged from 1,473–1,870 without signs of sepsis. Temporary elevation of other conventional biomarkers was observed postoperatively. Case 3: a 74-year-old woman with CKD on HD was admitted to the ICU after neurosurgery. She underwent intermittent HD postoperatively, and PSP ranged from 1,240–1,935 without sepsis symptoms. Temporary elevation of other conventional biomarkers was observed postoperatively. Case 4: a 62-year-old man with CKD was admitted to the ICU to control gastrointestinal bleeding. PSP was 606 without signs of infection or elevation of other conventional biomarkers. In cases 2, 3, and 4, bacteria were not isolated in blood cultures. Patients’ clinical prognoses were good, with low or moderate SIRS and APACHE II scores. PSP in kidney dysfunction patients will be high despite non-infectious conditions. Therefore, evaluation of PSP in kidney dysfunction patients will be difficult. Further investigation is needed to clarify the relationship between PSP and kidney dysfunction. |
format | Online Article Text |
id | pubmed-4336244 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-43362442015-02-22 A validation of presepsin levels in kidney dysfunction patients: four case reports Kotera, Atsushi Sagishima, Katsuyuki Tashiro, Takahiro Niimori, Daisuke Kamohara, Hidenobu Kinoshita, Yoshihiro J Intensive Care Letter to the Editor Here, we measured presepsins (PSPs) in four patients with acute kidney injury (AKI) or chronic kidney disease (CKD) and discuss the relationship between PSP and kidney dysfunction. Case 1: an 83-year-old man was admitted to the ICU to manage postoperative respiratory failure with AKI. He had undergone resection for rectal cancer and ileal conduit replacement. On day 1 in the ICU, Escherichia coli (E. coli) was isolated by urine culture. PSP level (pg/ml) on day 2 was 2,745 without elevation of other conventional biomarkers. On day 6, the patient was diagnosed with severe sepsis, and E. coli was isolated by blood culture. By then, PSP had risen to 3,977, along with elevation of other conventional biomarkers. His kidney function recovered gradually after continuous administration of hemodiafiltration; however, PSP continued to rise up to 6,051, along with high systemic inflammatory response syndrome (SIRS) and Acute Physiology and Chronic Health Evaluation (APACHE) II values. The patient expired on day 13 due to multiple organ failure. Case 2: a 78-year-old woman with CKD on hemodialysis (HD) was admitted to the ICU after cardiovascular surgery. Continuous HD was administered postoperatively, and PSP ranged from 1,473–1,870 without signs of sepsis. Temporary elevation of other conventional biomarkers was observed postoperatively. Case 3: a 74-year-old woman with CKD on HD was admitted to the ICU after neurosurgery. She underwent intermittent HD postoperatively, and PSP ranged from 1,240–1,935 without sepsis symptoms. Temporary elevation of other conventional biomarkers was observed postoperatively. Case 4: a 62-year-old man with CKD was admitted to the ICU to control gastrointestinal bleeding. PSP was 606 without signs of infection or elevation of other conventional biomarkers. In cases 2, 3, and 4, bacteria were not isolated in blood cultures. Patients’ clinical prognoses were good, with low or moderate SIRS and APACHE II scores. PSP in kidney dysfunction patients will be high despite non-infectious conditions. Therefore, evaluation of PSP in kidney dysfunction patients will be difficult. Further investigation is needed to clarify the relationship between PSP and kidney dysfunction. BioMed Central 2014-12-03 /pmc/articles/PMC4336244/ /pubmed/25705419 http://dx.doi.org/10.1186/s40560-014-0063-2 Text en © Atsushi et al.; licensee BioMed Central Ltd. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Letter to the Editor Kotera, Atsushi Sagishima, Katsuyuki Tashiro, Takahiro Niimori, Daisuke Kamohara, Hidenobu Kinoshita, Yoshihiro A validation of presepsin levels in kidney dysfunction patients: four case reports |
title | A validation of presepsin levels in kidney dysfunction patients: four case reports |
title_full | A validation of presepsin levels in kidney dysfunction patients: four case reports |
title_fullStr | A validation of presepsin levels in kidney dysfunction patients: four case reports |
title_full_unstemmed | A validation of presepsin levels in kidney dysfunction patients: four case reports |
title_short | A validation of presepsin levels in kidney dysfunction patients: four case reports |
title_sort | validation of presepsin levels in kidney dysfunction patients: four case reports |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4336244/ https://www.ncbi.nlm.nih.gov/pubmed/25705419 http://dx.doi.org/10.1186/s40560-014-0063-2 |
work_keys_str_mv | AT koteraatsushi avalidationofpresepsinlevelsinkidneydysfunctionpatientsfourcasereports AT sagishimakatsuyuki avalidationofpresepsinlevelsinkidneydysfunctionpatientsfourcasereports AT tashirotakahiro avalidationofpresepsinlevelsinkidneydysfunctionpatientsfourcasereports AT niimoridaisuke avalidationofpresepsinlevelsinkidneydysfunctionpatientsfourcasereports AT kamoharahidenobu avalidationofpresepsinlevelsinkidneydysfunctionpatientsfourcasereports AT kinoshitayoshihiro avalidationofpresepsinlevelsinkidneydysfunctionpatientsfourcasereports AT koteraatsushi validationofpresepsinlevelsinkidneydysfunctionpatientsfourcasereports AT sagishimakatsuyuki validationofpresepsinlevelsinkidneydysfunctionpatientsfourcasereports AT tashirotakahiro validationofpresepsinlevelsinkidneydysfunctionpatientsfourcasereports AT niimoridaisuke validationofpresepsinlevelsinkidneydysfunctionpatientsfourcasereports AT kamoharahidenobu validationofpresepsinlevelsinkidneydysfunctionpatientsfourcasereports AT kinoshitayoshihiro validationofpresepsinlevelsinkidneydysfunctionpatientsfourcasereports |